DAC Patient Recruitment, Remedy Health Media partner for clinical trial enrollment
DAC Patient Recruitment Services, an Imperial company focusing on clinical trial patient recruitment and retention, has partnered with Remedy Health Media, a health information and technology company, to offer clients exclusive access to millions of potential trial participants in one of the highest-concentration online environments of chronic condition patients and caregivers.
“Our exclusive agreement with Remedy Health Media provides a highly valuable and unique solution that addresses the evolving needs of patient recruitment and retention,” said Steve Swanson, CEO of DAC and president of Imperial. “Through a cadre of health experts, unique patient communities and e-empowered subjects, clinical teams are able to reach target populations by going beyond the limitations of traditional database models. These programs break new ground in the key area of affordability by bringing these high-impact solutions to a broader range of clinical studies.”
DAC’s CRO, medical device and biopharmaceutical clients receive optimal positioning of customized trial recruitment centers within Remedy’s online platform. Annually, Remedy reaches millions of patients and caregivers through various digital, mobile and point-of-care products. Each month, Remedy’s online sites attract over 30 million unique visitors actively seeking treatment options for medical conditions matching DAC’s 40+ areas of therapeutic focus.
Additionally, DAC’s clients will have the opportunity to leverage Remedy’s point-of-care reach to recruit highly specific patient populations, such as marketing opportunities in digital doctor-to-patient communications and ads placed in condition-specific print publications reaching over 10 million people. Remedy’s quarterly print publications, with a combined audience of over 16 million readers, are distributed at pharmacies and physicians’ offices nationwide.
“The strategic partnership brings a greater level of diversity to DAC’s existing service platform,” said Melynda Geurts, DAC’s vice president of operations. “Reaching actively engaged individuals about their disease and treatment options allows us to bring higher quality referrals to trials, thus positively impacting ROI for our clients. The Remedy platform takes the e-engaged outreach beyond the traditional healthcare sites.”
Dennis Upah, Remedy’s executive vice president of enterprise markets, said, “Remedy’s sites, including Healthcentral.com, consistently have the highest concentration of chronic disease patients and caregivers, who spend more time on our sites than competing health sites, according to third-party research companies. These patients are actively seeking treatments and other services within condition-specific communities. Remedy’s experience in engaging patients online and at point of care will ensure motivated and highly qualified referrals for our partners at DAC.”
Remedy also claims higher patient retention rates through its HIPAA-compliant, proprietary mobile medical adherence suite. DAC also has exclusive rights to market its clinical trials within an Umbrella Center prominently positioned within Remedy’s online flagship property, Healthcentral.com.
“Through our partnership with DAC Patient Recruitment, we are proud to provide our vast audience with additional resources and tools to help them navigate the clinical trial enrollment process,” said Michael Cunnion, CEO of Remedy Health Media. “By partnering with DAC we are filling a need for patients with chronic conditions while collaborating to create value for DAC’s client base.”